4. Mirzaei M, Poorolajal J, Khazaei S, Saatchi M. Survival rate of AIDS disease and mortality in HIV-infected patients in Hamadan, Iran: a registry-based retrospective cohort study (1997-2011). Int J STD AIDS 2013;24:859-866. PMID:
23970604
6. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis 2010;50 Suppl 3:S201-S207.
9. Awoyemi OB, Ige OM, Onadeko BO. Prevalence of active pulmonary tuberculosis in human immunodeficiency virus seropositive adult patients in University College Hospital, Ibadan, Nigeria. Afr J Med Med Sci 2002;31:329-332. PMID:
15027773
14. Choun K, Thai S, Pe R, Lorent N, Lynen L, van Griensven J. Incidence and risk factors for tuberculosis in HIV-infected patients while on antiretroviral treatment in Cambodia. Trans R Soc Trop Med Hyg 2013;107:235-242. PMID:
23324313
15. Maro I, Lahey T, MacKenzie T, Mtei L, Bakari M, Matee M, et al. Low BMI and falling BMI predict HIV-associated tuberculosis: a prospective study in Tanzania. Int J Tuberc Lung Dis 2010;14:1447-1453. PMID:
20937186
16. Radfar S, Taheri K, Namdari Tabar H. Executive instruction services at the Counseling Center Behavioral Disorders. Tehran: Ministry of Health and Medical Education; 2010. (Persian).
17. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children; 2006 [cited 2014 Oct 10]. Available from:
http://www.who.int/hiv/pub/guidelines/hivstaging/en/
.
18. Radfar S, Taheri K, Namdari Tabar H. Practical guidelines on how to provide consulting services in behavioral disorders centers. Tehran: Ministry of Health and Medical Education; 2009. (Persian).
19. Ministry of Health and Medical Education (MOHME). National guideline for HIV/AIDS control and treatment. Tehran: MOHME; 2011. (Persian).
21. Reid SE, Topp SM, Turnbull ER, Hatwiinda S, Harris JB, Maggard KR, et al. Tuberculosis and HIV control in sub-Saharan African prisons: “thinking outside the prison cell”. J Infect Dis 2012;205 Suppl 2:S265-S273.
23. Khawcharoenporn T, Apisarnthanarak A, Manosuthi W, Sungkanuparph S, Mundy LM. Isoniazid preventive therapy and 4-year incidence of pulmonary tuberculosis among HIV-infected Thai patients. Int J Tuberc Lung Dis 2012;16:336-341. PMID:
22230143
24. Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011;377:1588-1598. PMID:
21492926